Inception Growth Acquisition Limited (NASDAQ: IGTA) announced this afternoon that it has signed a non-binding letter of intent (LOI) to combine with AI company AgileAlgo.
Singapore-based AgileAlgo is a maker of enterprise-grade natural language code generator for machine-learning and data management platforms. It utilizes generative-AI techniques to automate AI code development and scaling to other technology stacks.
Under the terms of the agreement, AgileAlgo’s existing equity holders will roll 100% of their equity into the combined public company. Inception Growth expects to announce additional details regarding the proposed business combination once a definitive merger agreement is executed, but did not provide a timeline as to when that will occur.
Inception Growth raised a total of $104.5 million in gross proceeds during its December 2021 IPO and initially sought to find a business based in the U.S. and/or Asia that has a focus on the TMT, sports and entertainment, and/or non-gambling gaming sectors. The SPAC, however, saw 56.75% of its trust redeemed during an extension meeting in March, leaving it with $46.05 million post-vote.
As of now, Inception Growth has until September 13 to complete a business combination, but has the ability to extend its deadline by an additional nine months until June 13, 2024. The company is led by Chief Executive Officer and Chairman of the Board Paige E. Craig, and Chief Financial Officer Felix Yun Pun Wong.
Because there is no guarantee that this LOI will be completed, Inception Growth will remain in SPACInsider’s “Searching” column until a definitive agreement is signed.
At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...
DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...
Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...
At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...
Bold Eagle Acquisition Corp. announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BEAGU”, Thursday, October 24, 2024. The new SPAC plans to search for a combination target valued at $3 billion or more that would benefit from the relationships and experience...